Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

被引:435
|
作者
Suzuki, Rigel [1 ]
Yamasoba, Daichi [2 ,3 ]
Kimura, Izumi [2 ]
Wang, Lei [4 ,5 ]
Kishimoto, Mai [6 ]
Ito, Jumpei [2 ]
Morioka, Yuhei [1 ]
Nao, Naganori [7 ,8 ]
Nasser, Hesham [9 ,10 ]
Uriu, Keiya [2 ,11 ]
Kosugi, Yusuke [2 ,12 ,13 ]
Tsuda, Masumi [4 ,5 ]
Orba, Yasuko [6 ,14 ]
Sasaki, Michihito [6 ,14 ]
Shimizu, Ryo [9 ]
Kawabata, Ryoko [15 ]
Yoshimatsu, Kumiko [16 ]
Asakura, Hiroyuki [17 ]
Nagashima, Mami [17 ]
Sadamasu, Kenji [17 ]
Yoshimura, Kazuhisa [17 ]
Sawa, Hirofumi [6 ,7 ,8 ,14 ]
Ikeda, Terumasa [9 ]
Irie, Takashi [15 ]
Matsuno, Keita [8 ,14 ,18 ]
Tanaka, Shinya [4 ,5 ]
Fukuhara, Takasuke [1 ]
Sato, Kei [2 ,11 ,19 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Dept Microbiol & Immunol, Sapporo, Hokkaido, Japan
[2] Univ Tokyo, Int Res Ctr Infect Dis, Inst Med Sci, Dept Infect Dis Control,Div Syst Virol, Tokyo, Japan
[3] Kobe Univ, Fac Med, Kobe, Hyogo, Japan
[4] Hokkaido Univ, Fac Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan
[5] Hokkaido Univ, Inst Chem React Design & Discovery WPI ICReDD, Sapporo, Hokkaido, Japan
[6] Hokkaido Univ, Int Inst Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido, Japan
[7] Hokkaido Univ, Int Inst Zoonosis Control, Div Int Res Promot, Sapporo, Hokkaido, Japan
[8] Hokkaido Univ, Hlth Res Ctr 1, Sapporo, Hokkaido, Japan
[9] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Div Mol Virol & Genet, Kumamoto, Japan
[10] Suez Canal Univ, Fac Med, Dept Clin Pathol, Ismailia, Egypt
[11] Univ Tokyo, Grad Sch Med, Tokyo, Japan
[12] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Syst Virol, Kyoto, Japan
[13] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan
[14] Hokkaido Univ, Int Inst Zoonosis Control, Int Collaborat Unit, Sapporo, Hokkaido, Japan
[15] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima, Japan
[16] Hokkaido Univ, Inst Genet Med, Sapporo, Hokkaido, Japan
[17] Tokyo Metropolitan Inst Publ Hlth, Tokyo, Japan
[18] Hokkaido Univ, Int Inst Zoonosis Control, Div Risk Anal & Management, Sapporo, Hokkaido, Japan
[19] Japan Sci & Technol Agcy, CREST, Saitama, Japan
关键词
CELLS;
D O I
10.1038/s41586-022-04462-1
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The emergence of the Omicron variant of SARS-CoV-2 is an urgent global health concern(1). In this study, our statistical modelling suggests that Omicron has spread more rapidly than the Delta variant in several countries including South Africa. Cell culture experiments showed Omicron to be less fusogenic than Delta and than an ancestral strain of SARS-CoV-2.Although the spike (S) protein of Delta is efficiently cleaved into two subunits, which facilitates cell-cell fusion(2,3), the Omicron S protein was less efficiently cleaved compared to the S proteins of Delta and ancestral SARS-CoV-2. Furthermore, in a hamster model, Omicron showed decreased lung infectivity and was less pathogenic compared to Delta and ancestral SARS-CoV-2. Our multiscale investigations reveal the virological characteristics of Omicron, including rapid growth in the human population, lower fusogenicity and attenuated pathogenicity.
引用
收藏
页码:700 / +
页数:23
相关论文
共 50 条
  • [31] Audio Interview: Understanding the Omicron Variant of SARS-CoV-2
    Rubin, Eric J.
    Baden, Lindsey R.
    Morrissey, Stephen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (08): : E27 - E27
  • [32] Importation of SARS-CoV-2 Omicron variant in Beijing, China
    Li Fu
    Liang Zhichao
    Cui Shujuan
    Lv Bing
    Feng Zhaomin
    Xu Hui
    Jia Lei
    Yang Peng
    Wang Quanyi
    Pan Yang
    Zhang Daitao
    [J]. 生物安全与健康(英文), 2022, (03) : 150 - 153
  • [33] Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
    Wei, Changshuo
    Shan, Ke-Jia
    Wang, Weiguang
    Zhang, Shuya
    Huan, Qing
    Qian, Wenfeng
    [J]. JOURNAL OF GENETICS AND GENOMICS, 2021, 48 (12) : 1111 - 1121
  • [34] Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
    Changshuo Wei
    Ke-Jia Shan
    Weiguang Wang
    Shuya Zhang
    Qing Huan
    Wenfeng Qian
    [J]. Journal of Genetics and Genomics, 2021, 48 (12) : 1111 - 1121
  • [35] High rate of reinfection with the SARS-CoV-2 Omicron variant
    Nhu Ngoc Nguyen
    Houhamdi, Linda
    Van Thuan Hoang
    Stoupan, Didier
    Fournier, Pierre-Edouard
    Raoult, Didier
    Colson, Philippe
    Gautret, Philippe
    [J]. JOURNAL OF INFECTION, 2022, 85 (02) : 206 - 208
  • [36] Role of Omicron variant of SARS-CoV-2 in children in Germany
    Stefan Bittmann
    [J]. World Journal of Pediatrics, 2022, 18 : 283 - 284
  • [37] The mysterious origins of the Omicron variant of SARS-CoV-2 Comment
    Du, Pei
    Gao, George Fu
    Wang, Qihui
    [J]. INNOVATION, 2022, 3 (02):
  • [38] SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model
    Mache, Christin
    Schulze, Jessica
    Holland, Gudrun
    Bourquain, Daniel
    Gensch, Jean-Marc
    Oh, Djin-Ye
    Nitsche, Andreas
    Duerrwald, Ralf
    Laue, Michael
    Wolff, Thorsten
    [J]. COMMUNICATIONS BIOLOGY, 2022, 5 (01)
  • [39] SARS-CoV-2 omicron variant: Could it be another threat?
    Shanmugaraj, Balamurugan
    Malla, Ashwini
    Khorattanakulchai, Narach
    Phoolcharoen, Waranyoo
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (04) : 1284 - 1288
  • [40] SARS-CoV-2 Omicron Variant in Medicinal Chemistry Research
    Rocha, Weslany Souza
    Zhan, Peng
    da Silva-Junior, Edeildo Ferreira
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2023, 23 (17) : 1625 - 1639